MENU
ERAS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Erasca (ERAS) Ownership - Who owns Erasca?

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers... Show more

Profile

Industry
N/A
Address
3115 Merryfield Row
Phone
+1 858 465-6511
Employees
103
Web
https://www.erasca.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4B
P/E Ratio
N/A
Total Cash
243.79M
Projected Growth
N/A
Total Debt
45.95M
Revenue
N/A
Risk (Beta)
-0.45
Dividend Yield
N/A
Total Cash/Share
0.78
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
ERAS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
3115 Merryfield Row
Phone
+1 858 465-6511
Employees
103
Web
https://www.erasca.com